Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

A recent study found that antiretroviral therapy adherence below 90% was associated with significantly lower odds of viral suppression among women living with HIV. Researchers analyzed data from ...

In the early 1980s, as a physician at the University of California Medical Center, researching and treating sexually transmitted viral diseases, I found myself at the epicenter of an emerging crisis ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised ...

High stigma levels correlate with lower ART adherence and viral suppression in women with HIV, especially those who inject drugs. The study used data from the WIHS, focusing on stigma's impact on HIV ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

Access to life-saving HIV prevention medications varies by race and other sociodemographic factors. David Talukdar/Moment via Getty Images As a social epidemiologist who proudly identifies as a gay ...

Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...

Rakhants’a’s mother died when he was very young, leaving his grandmother to raise him. In 2007, when he was just 4 years old, ...